Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma (Q35103536)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma |
scientific article |
Statements
1 reference
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma (English)
1 reference
Joseph M Connors
1 reference
Ajay K Gopal
1 reference
Robert Chen
1 reference
Scott E Smith
1 reference
Stephen M Ansell
1 reference
Joseph D Rosenblatt
1 reference
Kerry J Savage
1 reference
Andreas Engert
1 reference
Emily K Larsen
1 reference
Xuedong Chi
1 reference
Eric L Sievers
1 reference
Anas Younes
1 reference
22 December 2014
1 reference
1 reference
Identifiers
1 reference